Clinical Trial Update: "Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

View source ↗

Summary

A completed clinical trial assessing the durability of neutralizing antibodies after yellow fever vaccination in HIV-infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Yellow Fever

Drugs mentioned

• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: HIV Infections, Yellow Fever Vaccine | Status: COMPLETED